Dr. Steven Pelech
Pelech is the President and Chief Scientific Officer of Kinexus Bioinformatics Corporation. He is concurrently a full professor in the Department of Medicine at the University of British Columbia (UBC), where he has been on faculty since 1988. He contributes leadership, vision and strategic planning to Kinexus with over twenty-five years experience in the areas of science, business and administration. He was the principal founder of Kinetek Pharmaceuticals, Inc. and served as its President and C.E.O. for six years and was one of the founding scientists of the Biomedical Research Center in Vancouver. Prior to his academic and industrial experience, he spent five years in post-doctoral training with Sir Philip Cohen at the University of Dundee in Scotland and Nobel laureate Edwin Krebs at the University of Washington in Seattle. Pelech received his B.Sc. (1979; Honours) and Ph.D. (1982) degrees in Biochemistry from UBC. Pelech has authored over 220 scientific publications in peer-reviewed journals and book chapters about signal transduction and is one of the discoverers of the MAP kinase family of cell signalling proteins. His accolades include the 1993 Martin F. Hoffman Award for Research at UBC, and the 1993 Merck Frosst Canada Prize from the Canadian Society of Biochemistry and Molecular Biology. He was the 2001 Distinguished Lecturer for the Faculty of Medicine at UBC for the basic sciences. He has served on grant review panels for the US National Institutes of Health, the Canadian Institutes for Health Research, the National Research of Canada, the Michael Smith Medical Health Research Foundation, Genome Canada, the Canadian Heart and Stroke Foundation and the American Heart Association, and he has acted as an external reviewer for 22 other agencies including the U.S. National Science Foundation and the Israel Science Foundation. He has also been an external reviewer for 30 scientific journals.